Hunan Shengjing Shanhe Biotechnology Co., Ltd. and all members of the board of directors guarantee the authenticity, accuracy, and completeness of the announcement content, and bear joint liability for any false records, misleading statements, or significant omissions in the announcement.
002525SZSE
Announcement on the Review Results of the Application for Initial Public Offering Not Approved by the Post-Meeting Review Committee
✨ AI Summary
Hunan Shengjing Shanhe Biotechnology Co., Ltd. announced that its application for an initial public offering was not approved by the China Securities Regulatory Commission's review committee on April 6, 2011. The company is required to refund online and offline investors at the issuance price plus bank interest. Further announcements regarding subsequent matters will be made.
Summary generated by AI · Always verify with source document
Full Translation
AI Translation· azure_openai
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.